Deadline: 21-Nov-2025
The Bio-Techne Reagent Grant Program offers stem cell and organoid researchers an opportunity to receive $10,000 in reagent credits for innovative projects in disease modeling, regenerative medicine, and tissue engineering. The program evaluates applications based on innovation, impact, and workflow integration, supporting basic, translational, and preclinical research. Applications are due November 21, 2025, with winners announced on January 16, 2026.
Bio-Techne Reagent Grant Program for Stem Cell and Organoid Research
Overview
Bio-Techne is inviting applications for its Reagent Grant Program to empower researchers working with stem cells and organoids. The program provides grant awards in the form of reagent credits for Bio-Techne products, enabling scientists to advance projects in developmental biology, disease modeling, tissue engineering, and regenerative medicine.
The grants aim to support innovative research while facilitating access to high-quality reagents, including proteins, small molecules, cell culture products, antibodies, and ELISA kits.
Why It Matters
Advancing stem cell and organoid research is critical for:
-
Understanding disease mechanisms
-
Developing regenerative therapies
-
Improving tissue engineering techniques
-
Enabling translational and preclinical research
By providing reagent credits, Bio-Techne reduces financial barriers, allowing researchers to focus on scientific innovation rather than product procurement.
Who is Eligible?
Eligible applicants must meet the following criteria:
-
Affiliated with a legally registered research institution, biotech, or pharmaceutical organization
-
Working on stem cell or organoid research projects
-
Not practicing medical physicians
-
Permitted by their institution to receive free-of-charge research reagents
Applications are accepted from multiple countries, including India.
Grant Details
-
Number of awards: 3 grants per cycle
-
Grant value: $10,000 each, provided as reagent credits
-
Redeemable products: Bio-Techne brands including R&D Systems, Tocris, and Novus Bio
-
Research scope: Basic, translational, or preclinical projects
-
Data ownership: Researchers retain full ownership of all findings or generated data
Key Evaluation Criteria
Applications will be evaluated on three main factors:
-
Innovation – Novelty of the proposed research and how it advances stem cell or organoid science.
-
Impact – Potential to enhance understanding or applications in disease modeling, tissue engineering, regenerative medicine, or cell therapy.
-
Workflow Application – Integration of multiple Bio-Techne products in the experimental design, including proteins, small molecules, antibodies, and ELISA kits.
How to Apply
-
Complete the official online application form.
-
Submit up to two proposals per applicant.
-
Provide a detailed research plan, including:
-
Motivation and scientific rationale
-
Project goals and experimental design
-
Required Bio-Techne reagents
-
-
Applications must be submitted in English by November 21, 2025.
-
AI tools may assist in prescreening to ensure alignment with evaluation criteria.
Timeline
-
Application deadline: November 21, 2025
-
Announcement of winners: January 16, 2026
-
Acceptance window: 14 days post-announcement
-
Reagent redemption: Within six months of award notification
Tips for a Strong Application
-
Clearly highlight innovative aspects and potential impact
-
Demonstrate integration of multiple Bio-Techne products in the workflow
-
Provide concise, well-structured project goals and experimental design
-
Emphasize translational or preclinical relevance if applicable
Expected Outcomes and Deliverables
-
Use of Bio-Techne reagents in research experiments
-
Potential participation in Bio-Techne promotional activities such as webinars, case studies, or spotlight features
-
Generation of data or findings with full ownership retained by the awardee
Frequently Asked Questions (FAQ)
1. Can I submit more than one proposal?
Yes, each applicant can submit up to two proposals.
2. Who can receive the reagent credits?
Researchers from eligible institutions who are not practicing medical physicians and are permitted by their institution to receive free-of-charge reagents.
3. What types of projects are supported?
Projects can be basic, translational, or preclinical research in stem cell or organoid science.
4. Which Bio-Techne products are eligible for reagent credits?
Products include proteins, small molecules, cell culture reagents, antibodies, and ELISA kits from brands such as R&D Systems, Tocris, and Novus Bio.
5. Who retains ownership of the research data?
All research findings and data generated with awarded reagents remain the property of the grant recipient.
6. When must reagent credits be redeemed?
Reagent credits must be redeemed within six months of award notification.
7. Are self-nominations allowed?
Yes, both self-nominations and third-party nominations are accepted.
Conclusion
The Bio-Techne Reagent Grant Program offers a unique opportunity for stem cell and organoid researchers to access high-quality reagents, accelerate innovation, and advance scientific discovery. By funding creative and impactful projects, the program supports the development of cutting-edge research in regenerative medicine, disease modeling, and tissue engineering. Applications close November 21, 2025, and selected recipients will be notified on January 16, 2026.
For more information, visit R&D Systems.